Fierce Pharma

SEPTEMBER 6, 2024

GSK is heading into the weekend with a win for its respiratory blockbuster Nucala—but for now, the details are slim. | On Friday, GSK said that its IL-5 antibody Nucala plus inhaled maintenance therapy lowered the annualized rate of moderate or severe exacerbations among chronic obstructive pulmonary disease (COPD) patients for up to 2 years. Nucala is already approved in a range of respiratory conditions, but a COPD nod could present another big opportunity for the drug.

FDA 302

FDA Patients 302

MedCity News

SEPTEMBER 6, 2024

By 2030, the U.S. expects shortages of 200,000 nurses and 124,000 physicians snd similar shortages are already being felt in the U.K. and elsewhere. Here’s how to build and train a modern healthcare workforce in the age of AI The post Can AI Help Fix Our Demographic Time Bomb? appeared first on MedCity News.

Physicians 115

Physicians Training Healthcare Healthcare 115

Fierce Pharma

SEPTEMBER 6, 2024

Gilead Sciences has been looking for a win for Trodelvy after two surprise trial failures earlier this year. | Gilead Sciences has been looking for a win for Trodelvy after two surprise trial failures earlier this year. But it looks like that win won’t come from a triplet regimen that combines the antibody-drug conjugate with Merck’s Keytruda and chemotherapy in newly diagnosed non-small cell lung cancer.

253

253

pharmaphorum

SEPTEMBER 6, 2024

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.

109

109

Advertisement

Fierce Pharma

SEPTEMBER 6, 2024

Astellas is closing a gene therapy manufacturing facility in South San Francisco. But, across the country, the company opened a new R&D center in Massachusetts. | Astellas is closing a gene therapy manufacturing facility in South San Francisco. But across the country, the company opened a new R&D center in Massachusetts. Chinese authorities detained several current or former AstraZeneca employees.

Manufacturing 130

Manufacturing Pharma 130

MedCity News

SEPTEMBER 6, 2024

Local health department staffing grew by about 19% from 2019 to 2022, according to a report from the National Association of County and City Health Officials that studied 2,512 of the nation’s roughly 3,300 local departments. But those jobs, and the safety net they provide for the people in the communities served, are vulnerable as the money dries up, The post Boom, Now Bust: Budget Cuts and Layoffs Take Hold in Public Health appeared first on MedCity News.

Safety 109

Safety 109

MedCity News

SEPTEMBER 6, 2024

The FDA decision for Travere Therapeutics’ Filspari also expands its addressable patient population. The full approval comes nearly a year after the Travere drug narrowly missed the main goal of its confirmatory study. The post Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas appeared first on MedCity News.

Competition 108

Competition FDA Patients Biopharma 108

Pharmaceutical Technology

SEPTEMBER 6, 2024

The US FDA has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD-147 aimed at neuroendocrine carcinoma.

FDA 124

FDA 124

MedCity News

SEPTEMBER 6, 2024

Check out news from Oral Genome, Carrot Fertility, Thatch, and The Perryman Group. The post StartUPDATES: New Developments for Healthcare Startups appeared first on MedCity News.

Healthcare 102

Healthcare Healthcare Biopharma 102

pharmaphorum

SEPTEMBER 6, 2024

Financings in the biotech sector this week include an IPO filing for BioAge and private rounds for eGenesis, Navigator, and Circle Pharma.

Pharma 109

Pharma 109

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

SEPTEMBER 6, 2024

By actively and consistently collecting feedback, hospitals can gain rapid insights into critical areas, allowing them to track and measure patient satisfaction levels, and crucially to react to any dips in standards of care. The post How Data Feedback Can Aid Patient Experience in Healthcare appeared first on MedCity News.

Healthcare 96

Healthcare Healthcare Patients 96

pharmaphorum

SEPTEMBER 6, 2024

Eli Lilly signs another genetic medicines deal, this time with Genetic Leap, a start-up that applies AI to the discovery of RNA-targeted drugs.

Medicine 102

Medicine 102

Dinamic OR

SEPTEMBER 6, 2024

Enhancing Cross-Functional Collaboration with DinamicOR’s Surgical Back Table and Workflow Management App In today’s healthcare environment, cross-functional teams are becoming increasingly essential, especially in operating rooms (ORs) where staff shortages are a growing concern. The shift toward interdisciplinary collaboration isn’t just a trend—it’s a necessity.

Management 83

Management Safety Healthcare Healthcare 83

Pharmaceutical Technology

SEPTEMBER 6, 2024

The US FDA has approved Amneal Pharmaceuticals and Shilpa Medicare’s oncology product BORUZU for subcutaneous administration.

FDA 98

FDA Pharmaceutical 98

Advertisement

Distribution

MedCity News

SEPTEMBER 6, 2024

Mayo Clinic recently launched a collaboration with Exer AI, a Denver-based startup. The AI company seeks to improve diagnosis and treatment for musculoskeletal and motion disorders wherever the patient is — whether that be in their provider’s office, their home or via telehealth appointment. The post Mayo Clinic Taps AI Startup to Improve MSK Care appeared first on MedCity News.

Patients 70

Patients Healthcare Healthcare 70

PharmaTimes

SEPTEMBER 6, 2024

New treatment could simplify diabetes management for millions

Management 100

Management 100

Healthcare Success

SEPTEMBER 6, 2024

On August 14, 2024, the Federal Trade Commission (FTC) introduced a rule banning fake reviews and misleading testimonials to improve marketing transparency and authenticity. As a healthcare organization, you already prioritize ethical practices and HIPAA compliance due to the nature of your business. It’s important to adapt to these new changes to maintain patient trust and remain competitive.

Ethics 58

Ethics Media Training Healthcare 58

European Pharmaceutical Review

SEPTEMBER 6, 2024

Results from a Phase I/II gene therapy trial have demonstrated that ATSN-101 enabled patients with a rare inherited disease to gain substantial, rapid improvement in their vision. Participants with Leber congenital amaurosis (LCA1) due to mutations in the GUCY2D gene were evaluated in the one-year clinical trial. Of the 15 participants, three were paediatric subjects.

Patients 52

Patients Leads Pharmaceutical 52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

PharmExec

SEPTEMBER 6, 2024

Results from the MATINEE trial found that Nucala led to a statistically significant and clinically meaningful reduction in moderate/severe exacerbations of chronic obstructive pulmonary disease compared to placebo over 104 weeks.

52

52

Pharmaceutical Commerce

SEPTEMBER 6, 2024

In the final part of her interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, comments on industry’s preparedness for DSCSA compliance and provides an update as to where pharma is in terms of RFID label adoption.

Pharma 52

Pharma 52

PharmExec

SEPTEMBER 6, 2024

Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.

Medical 52

Medical 52

Pharmaceutical Commerce

SEPTEMBER 6, 2024

The enhancement—which complements the CDMO’s adeno-associated viral vector services—will be utilized at the company’s advanced therapies site in Stevenage, UK.

Biopharma 52

Biopharma Manufacturing 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmExec

SEPTEMBER 6, 2024

Texas Biomed announced that research shows that a certain monoclonal antibody treatment could treat all variants of COVID-19, including past, present, and future strains.

52

52

Pharmaceutical Technology

SEPTEMBER 6, 2024

The atopic dermatitis market is facing increased growth, with a projected market value of $16.7bn by 2030 for the 7MM, according to GlobalData.

Marketing 52

Marketing 52

PharmExec

SEPTEMBER 6, 2024

Boruzu is the first ready-to-use version of bortezomib for subcutaneous and intravenous administration in the treatment of multiple myeloma and mantle cell lymphoma.

FDA 52

FDA 52

Pharmaceutical Technology

SEPTEMBER 6, 2024

German life science company Evotec has announced a collaboration with X-Chem to accelerate early-stage drug discovery-leveraging technology.

52

52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

PharmExec

SEPTEMBER 6, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma 52

PharmaTech

SEPTEMBER 6, 2024

Viral vectors and other complex biologic modalities require more specificity and higher sensitivity to detect and distinguish contaminants.

52

52

PharmExec

SEPTEMBER 6, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Technology

SEPTEMBER 6, 2024

The company had focused its resources on Filspari’s launch in IgAN after the US FDA snubbed the therapy in another rare kidney disorder.

FDA 52

FDA 52

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization